The CHADS-VASc score is a predictor of no-reflow in patients with non-ST-segment elevation myocardial infarction-Reference-Cited by-同舟云学术

The CHADS-VASc score is a predictor of no-reflow in patients with non-ST-segment elevation myocardial infarction

Published:2020-01 Issue:1 Volume:31 Page:7-12
ISSN:0954-6928
Container-title:Coronary Artery Disease
language:en
Short-container-title:

Author:

Barman Hasan Ali,Kahyaoglu Serdar,Durmaz Eser,Atici Adem,Gulsen Kamil,Tugrul Sevil,Isleyen Hasan Burak,Yildirim Mehmet Rifat,Gungor Baris,Okuyan Ertugrul,Sahin Irfan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference34 articles.

1. Trends in mortality from ischemic heart disease and cerebrovascular disease in Europe: 1980 to 2009.;Hartley;Circulation,2016

2. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).;Ibanez;Eur Heart J,2018

3. Pathology of coronary microembolisation and no reflow.;Falk;Heart,2003

4. Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction.;Ito;Circulation,1992

5. Clinical implications of the ‘no reflow’ phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction.;Ito;Circulation,1996

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship Between CHA₂DS₂-VASc Score on Admission and In-Hospital Major Adverse Cardiovascular Events in Patients Diagnosed With ST-Elevation Myocardial Infarction;Angiology;2024-08-12

2. Association between R2CHA2DS2-VASc score and three-vessel coronary artery disease in a large population at high cardiovascular risk;Internal and Emergency Medicine;2024-07-06

3. No-Reflow Prediction in Acute Coronary Syndrome During Percutaneous Coronary Intervention: The NORPACS Risk Score;Circulation: Cardiovascular Interventions;2024-04

4. Thromboembolic risk scores in patients with non-obstructive coronary architecture with and without coronary slow flow: A case-control study;International Journal of Cardiology;2023-08

5. Predictive value of CHA2DS2VASC score for contrast-induced nephropathy after primary percutaneous coronary intervention for patients presenting with acute ST-segment elevation myocardial infarction;The Egyptian Heart Journal;2023-06-26